MARKET

RPTX

RPTX

Repare Therapeutics Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

25.15
-1.11
-4.23%
Closed 16:00 07/10 EDT
OPEN
25.84
PREV CLOSE
26.26
HIGH
26.10
LOW
25.05
VOLUME
169.24K
TURNOVER
--
52 WEEK HIGH
34.00
52 WEEK LOW
25.01
MARKET CAP
856.55M
P/E (TTM)
-22.6515
1D
5D
1M
3M
1Y
5Y

RPTX News

More
The Week Ahead In Biotech: J&J Kickstarts Pharma Earnings, Repare Therapeutics IPO
Biotech stocks advanced in the week ended July 10 amid mixed news flow emerging out of the sector.
Benzinga · 10h ago
The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 9) Affimed NV (NASDAQ: AFMD)
Benzinga · 2d ago
The Daily Biotech Pulse: Intersect ENT Jumps On M&A Speculation, VIVUS Files For Bankruptcy
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7)
Benzinga · 4d ago
Leaf Group, Forma Therapeutics See Activist Action
Barrons.com · 07/03 00:30
The Daily Biotech Pulse: Novartis Settles Lawsuit For $678M, Sarepta In-Licenses Gene Therapy Pre-Treatment, Unity Biotech Outlines Second-Half Catalysts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 1)
Benzinga · 07/02 12:21
Repare Therapeutics 13D Filing From Orbimed Advisors Shows 8.9% Stake
Benzinga · 06/26 10:14
Repare Therapeutics Announces Closing of Upsized Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
Repare Therapeutics Inc. (Nasdaq: RPTX), a leading precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics, today announced the closing of its previously announced upsized initia
Business Wire · 06/23 20:05
Shares Of Repare Therapeutics Open For Trade At $32.05; IPO Priced At $20/Share
Benzinga · 06/19 15:55

Industry

Biotechnology & Medical Research
-0.39%
Pharmaceuticals & Medical Research
-0.32%

Hot Stocks

Symbol
Price
%Change

About RPTX

Repare Therapeutics Inc is a Canada-based precision oncology company targeting specific vulnerabilities of tumors in genetically defined patient populations. Its approach integrates discoveries from several fields of cell biology including deoxyribonucleic acid (DNA) repair and synthetic lethality. Its SNIPRx platform combines a clustered regularly interspaced short palindromic repeats (CRISPR)-enabled gene editing target discovery method with protein crystallography, computational biology and clinical informatics. The Company’s pipeline products are RP-3500, Manchester and Pol0.
More

Webull offers kinds of Repare Therapeutics Inc stock information, including NASDAQ:RPTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RPTX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RPTX stock methods without spending real money on the virtual paper trading platform.